Folate intake and risk of bladder cancer: A meta-analysis of epidemiological studies

International Journal of Food Sciences and Nutrition

Volumn 65, Issue 3, 2014, Pages 286-292

  He, Huadong ^a   Shui, Bing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Folate; Meta analysis; Prostate cancer

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

HUMAN; META ANALYSIS; URINARY BLADDER NEOPLASMS;

FOLIC ACID; HUMANS; URINARY BLADDER NEOPLASMS; VITAMIN B COMPLEX;

EID: 84898403275     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2013.866641     Document Type: Article

References (39)

1. Aune D, Deneo-Pellegrini H, Ronco AL, Boffetta P, Acosta G, Mendilaharsu M, De Stefani E. 2011. Dietary folate intake and the risk of 11 types of cancer: a case-control study in Uruguay. Ann Oncol 22:444-451.
2. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
3. Brinkman MT, Karagas MR, Zens MS, Schned A, Reulen RC, Zeegers MP. 2010. Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control 21:609-619.
4. Bruemmer B, White E, Vaughan TL, Cheney CL. 1996. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 144:485-495.
5. Choi SW, Mason JB. 2000. Folate and carcinogenesis: an integrated scheme. J Nutr 130:129-132.
6. Dai WM, Yang B, Chu XY, Wang YQ, Zhao M, Chen L, Zhang GQ. 2013. Association between folate intake, serum folate levels and the risk of lung cancer: a systematic review and meta-analysis. Chin Med J (Engl) 126:1957-1964.
7. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
8. Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G 2002. Impact of folate deficiency on DNA stability. J Nutr 132:2444S-2449S.
9. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634.
10. Eichholzer M, Luthy J, Moser U, Fowler B. 2001. Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly 131:539-549.
11. Enokida H, Nakagawa M. 2008. Epigenetics in bladder cancer. Int J Clin Oncol 13:298-307.
12. Garcia-Closas R, Garcia-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, Tardon A, et al. 2007. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 43:1731-1740.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003. Measuring inconsistency in meta-analyses. BMJ 327:557-560.
14. Hoffman AM, Cairns P. 2011. Epigenetics of kidney cancer and bladder cancer. Epigenomics 3:19-34.
15. Holick CN, De Vivo I, Feskanich D, Giovannucci E, Stampfer M, Michaud DS. 2005. Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States). Cancer Causes Control 16:1135-1145.
16. Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP, White E. 2011. Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. J Urol 185:1210-1215.
17. Huang YK, Pu YS, Chung CJ, Shiue HS, Yang MH, Chen CJ, Hsueh YM. 2008. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility. Food Chem Toxicol 46:929-938.
18. Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, Koren G 2012. Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: a systematic review and meta-analysis. J Cancer Epidemiol 2012:952508. doi: 10.1155/2012/952508.
19. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, Koren G 2011. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 35:2-10.
20. Larsson SC, Giovannucci E, Wolk A. 2006. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131:1271-1283.
21. Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ. 2006. Prevention of bladder cancer: a review. Eur Urol 49: 226-234.
22. Lin HL, An QZ, Wang QZ, Liu CX. 2013. Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis. Public Health 127:607-613.
23. Liu XM, Liu FH, Tang Y, Li Q. 2012. MTHFR C677T polymorphism and pancreatic cancer risk: a meta-analysis. Asian Pac J Cancer Prev 13: 3763-3766.
24. Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D. 2002. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer 87:960-965.
25. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci E. 2000. Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152:1145-1153.
26. Molloy AM, Scott JM. 2001. Folates and prevention of disease. Public Health Nutr 4:601-609.
27. Park SY, Ollberding NJ, Woolcott CG, Wilkens LR, Henderson BE, Kolonel LN. 2013. Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study. J Nutr 143:1283-1292.
28. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. 2005. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338: 284-293.
29. Roswall N, Olsen A, Christensen J, Dragsted LO, Overvad K, Tjonneland A. 2009. Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort. Eur Urol 56:764-770.
30. Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X. 2005. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer 53:144-151.
31. Shen H, Wei Q, Pillow PC, Amos CI, Hong WK, Spitz MR. 2003. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev 12:980-986.
32. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
33. Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, et al. 2009. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27: 295-300.
34. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
35. Ulrich CM, Potter JD. 2007. Folate and cancer-timing is everything. JAMA 297:2408-2409.
36. Volanis D, Papadopoulos G, Doumas K, Gkialas I, Delakas D. 2011. Molecular mechanisms in urinary bladder carcinogenesis. J BUON 16: 589-601.
37. Wu JW, Cross AJ, Baris D, Ward MH, Karagas MR, Johnson A, Schwenn M, et al. 2012. Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States. Br J Cancer 106: 1891-1898.
38. Zeegers MP, Goldbohm RA, van den Brandt PA. 2001. Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study. Br J Cancer 85:977-983.
39. Zhao X, Li H, Lee RJ. 2008. Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 5:309-319.